Emma Maund1, Beth Stuart1, Michael Moore1, Christopher Dowrick2, Adam W A Geraghty1, Sarah Dawson3, Tony Kendrick4. 1. Primary Care & Population Sciences, University of Southampton, Aldermoor Health Centre, Southampton, United Kingdom. 2. Institute of Psychology Health and Society, University of Liverpool, Liverpool, United Kingdom. 3. Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. 4. Primary Care & Population Sciences, University of Southampton, Aldermoor Health Centre, Southampton, United Kingdom A.R.Kendrick@soton.ac.uk.
Abstract
PURPOSE: We aimed to determine the effectiveness of interventions to manage antidepressant discontinuation, and the outcomes for patients. METHODS: We conducted a systematic review with narrative synthesis and meta-analysis of studies published to March 2017. Studies were eligible for inclusion if they were randomized controlled trials, quasi-experimental studies, or observational studies assessing interventions to facilitate discontinuation of antidepressants for depression in adults. Our primary outcomes were antidepressant discontinuation and discontinuation symptoms. Secondary outcomes were relapse/recurrence; quality of life; antidepressant reduction; and sexual, social, and occupational function. RESULTS: Of 15 included studies, 12 studies (8 randomized controlled trials, 2 single-arm trials, 2 retrospective cohort studies) were included in the synthesis. None were rated as having high risk for selection or detection bias. Two studies prompting primary care clinician discontinuation with antidepressant tapering guidance found 6% and 7% of patients discontinued, vs 8% for usual care. Six studies of psychological or psychiatric treatment plus tapering reported cessation rates of 40% to 95%. Two studies reported a higher risk of discontinuation symptoms with abrupt termination. At 2 years, risk of relapse/recurrence was lower with cognitive behavioral therapy plus taper vs clinical management plus taper (15% to 25% vs 35% to 80%: risk ratio = 0.34; 95% CI, 0.18-0.67; 2 studies). Relapse/recurrence rates were similar for mindfulness-based cognitive therapy with tapering and maintenance antidepressants (44% to 48% vs 47% to 60%; 2 studies). CONCLUSIONS: Cognitive behavioral therapy or mindfulness-based cognitive therapy can help patients discontinue antidepressants without increasing the risk of relapse/recurrence, but are resource intensive. More scalable interventions incorporating psychological support are needed.
PURPOSE: We aimed to determine the effectiveness of interventions to manage antidepressant discontinuation, and the outcomes for patients. METHODS: We conducted a systematic review with narrative synthesis and meta-analysis of studies published to March 2017. Studies were eligible for inclusion if they were randomized controlled trials, quasi-experimental studies, or observational studies assessing interventions to facilitate discontinuation of antidepressants for depression in adults. Our primary outcomes were antidepressant discontinuation and discontinuation symptoms. Secondary outcomes were relapse/recurrence; quality of life; antidepressant reduction; and sexual, social, and occupational function. RESULTS: Of 15 included studies, 12 studies (8 randomized controlled trials, 2 single-arm trials, 2 retrospective cohort studies) were included in the synthesis. None were rated as having high risk for selection or detection bias. Two studies prompting primary care clinician discontinuation with antidepressant tapering guidance found 6% and 7% of patients discontinued, vs 8% for usual care. Six studies of psychological or psychiatric treatment plus tapering reported cessation rates of 40% to 95%. Two studies reported a higher risk of discontinuation symptoms with abrupt termination. At 2 years, risk of relapse/recurrence was lower with cognitive behavioral therapy plus taper vs clinical management plus taper (15% to 25% vs 35% to 80%: risk ratio = 0.34; 95% CI, 0.18-0.67; 2 studies). Relapse/recurrence rates were similar for mindfulness-based cognitive therapy with tapering and maintenance antidepressants (44% to 48% vs 47% to 60%; 2 studies). CONCLUSIONS: Cognitive behavioral therapy or mindfulness-based cognitive therapy can help patients discontinue antidepressants without increasing the risk of relapse/recurrence, but are resource intensive. More scalable interventions incorporating psychological support are needed.
Authors: Willem Kuyken; Rachel Hayes; Barbara Barrett; Richard Byng; Tim Dalgleish; David Kessler; Glyn Lewis; Edward Watkins; Claire Brejcha; Jessica Cardy; Aaron Causley; Suzanne Cowderoy; Alison Evans; Felix Gradinger; Surinder Kaur; Paul Lanham; Nicola Morant; Jonathan Richards; Pooja Shah; Harry Sutton; Rachael Vicary; Alice Weaver; Jenny Wilks; Matthew Williams; Rod S Taylor; Sarah Byford Journal: Lancet Date: 2015-04-20 Impact factor: 79.321
Authors: Willem Kuyken; Sarah Byford; Richard Byng; Tim Dalgleish; Glyn Lewis; Rod Taylor; Edward R Watkins; Rachel Hayes; Paul Lanham; David Kessler; Nicola Morant; Alison Evans Journal: Trials Date: 2014-06-10 Impact factor: 2.279
Authors: João Mauricio Castaldelli-Maia; Caio Hofmann; Antonio Carlos Palandri Chagas; Alvaro Sosa Liprandi; Alejandro Alcocer; Laura H Andrade; Andreas Wielgosz Journal: Cardiovasc Drugs Ther Date: 2021-06 Impact factor: 3.727
Authors: Ellen Van Leeuwen; Mieke L van Driel; Mark A Horowitz; Tony Kendrick; Maria Donald; An Im De Sutter; Lindsay Robertson; Thierry Christiaens Journal: Cochrane Database Syst Rev Date: 2021-04-15
Authors: Alice Tickell; Richard Byng; Catherine Crane; Felix Gradinger; Rachel Hayes; James Robson; Jessica Cardy; Alice Weaver; Nicola Morant; Willem Kuyken Journal: BMJ Open Date: 2020-02-18 Impact factor: 2.692
Authors: Ali Elbeddini; Monakshi Sawhney; Yasamin Tayefehchamani; Zekiye Yilmaz; Ahmed Elshahawi; Josiah Josh Villegas; Janelyn Dela Cruz Journal: BMJ Open Qual Date: 2021-07
Authors: Hannah M Bowers; Tony Kendrick; Marta Glowacka; Samantha Williams; Geraldine Leydon; Carl May; Chris Dowrick; Joanna Moncrieff; Rebecca Laine; Yvonne Nestoriuc; Gerhard Andersson; Adam W A Geraghty Journal: BMJ Open Date: 2020-03-08 Impact factor: 2.692